Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Successful Pregnancy After Planned Pregnancy‐Oriented TKI Interruption and Embryo Transfer Following Ponatinib Re‐Consolidation in Chronic‐Phase Chronic Myeloid Leukemia. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1200/jco.2015.66.2866
10.1200/jco.2015.66.2866 · External reference
10.1016/s1470‐2045(10)70233‐3
10.1016/s1470‐2045(10)70233‐3 · External reference
10.1038/s41375‐025‐02664‐w
10.1038/s41375‐025‐02664‐w · External reference
10.1038/leu.2015.73
10.1038/leu.2015.73 · External reference
10.1016/j.beha.2009.09.008
10.1016/j.beha.2009.09.008 · External reference
10.1182/blood‐2007‐10‐114900
10.1182/blood‐2007‐10‐114900 · External reference
How I Manage Chronic Myeloid Leukemia During Pregnancy
10.1182/blood.2024026513 · 2026 · External reference
Outcomes of Pregnancy in Patients With Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors
10.1002/cncr.35611 · 2025 · External reference
Nilotinib vs Dasatinib in Achieving MR4.5 for De Novo Chronic Myeloid Leukemia: The Randomized JALSG CML212 Study
10.1182/bloodadvances.2024012655 · 2024 · External reference
10.1111/bjh.70678
10.1111/bjh.70678 · External reference
10.1002/cncr.30885
10.1002/cncr.30885 · External reference
10.1111/bjh.18796
10.1111/bjh.18796 · External reference
Treatment‐Free Remission After a Second TKI Discontinuation Attempt in Patients With Chronic Myeloid Leukemia Re‐Treated With Dasatinib—Interim Results From the DAstop2 Trial
10.1038/s41375-024-02145-6 · 2024 · External reference
10.3390/jcm11071801
10.3390/jcm11071801 · External reference
10.2169/internalmedicine.3322‐23
10.2169/internalmedicine.3322‐23 · External reference
